HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemolytic uremic syndrome and metastatic malignancy.

Abstract
We report a case of hemolytic uremic syndrome (HUS) with advanced renal failure and metastatic adenocarcinoma of the prostate. The HUS rapidly improved after treatment with blood transfusions, Plasmanate infusions, aspirin and dipyridamole, and hemodialysis for uremia. No cancer chemotherapy was given. This case illustrates that, in adults, HUS may have an excellent prognosis even with advanced renal failure, and that the presence of metastatic cancer does not necessarily imply a relationship between the two diseases.
AuthorsJ Milutinovic, S Irby, M Fisher
JournalSouthern medical journal (South Med J) Vol. 75 Issue 11 Pg. 1409-11 (Nov 1982) ISSN: 0038-4348 [Print] United States
PMID7146974 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Diethylstilbestrol
Topics
  • Acute Kidney Injury (etiology, pathology)
  • Adenocarcinoma (secondary)
  • Blood Transfusion
  • Diethylstilbestrol (therapeutic use)
  • Hemolytic-Uremic Syndrome (complications, therapy)
  • Humans
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Prognosis
  • Prostatic Neoplasms (secondary)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: